Jump Trading’s Lexicon Pharmaceuticals LXRX Stock Holding History

Jump Trading’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,571	Closed	-$104K	–	408
2017 Q4	$104K	Buy	+10,571	New	+$110K	0.01%	335

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UIM

USS Investment Management London, United Kingdom $27.8B AUM 39.42% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

CLM

ClearBridge LLC (Maryland) Baltimore, Maryland $329M AUM 9.73% 1-Year Est. Return

Jump Trading's LXRX Position: Q1 2018 in Review

Jump Trading sold out of Lexicon Pharmaceuticals (LXRX) in Q1 2018, closing a stake of 10,571 shares — an estimated $104K sold.

Jump Trading first reported a position in LXRX in Q4 2017 and held it in 1 quarter. The position peaked at $104K in Q4 2017. 126 funds tracked by Wall St. Rank hold LXRX as of Q1 2018.

Jump Trading reported no remaining Lexicon Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
Jump Trading sold 10,571 Lexicon Pharmaceuticals shares in Q1 2018, an estimated $104K.
Jump Trading first reported a position in Lexicon Pharmaceuticals in Q4 2017 and held it in 1 quarter.
Jump Trading's Lexicon Pharmaceuticals position peaked at $104K in Q4 2017.
126 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2018.

Based on Jump Trading's 13F filing for Q1 2018, filed 11 May 2018.